Slingshot members are tracking this event:

Phase II simtuzumab HVPG cirrhosis data in portal hypertension expected near year end of 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
GILD Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Simtuzumab, Hvpg Cirrhosis, Portal Hypertension